Analyze Diet
Cell biology international2010; 35(3); 235-248; doi: 10.1042/CBI20090211

Effects of non-steroidal anti-inflammatory drugs on proliferation, differentiation and migration in equine mesenchymal stem cells.

Abstract: In equine medicine, stem cell therapies for orthopaedic diseases are routinely accompanied by application of NSAIDs (non-steroidal anti-inflammatory drugs). Thus, it has to be analysed how NSAIDs actually affect the growth and differentiation potential of MSCs (mesenchymal stem cells) in vitro in order to predict the influence of NSAIDs such as phenylbutazone, meloxicam, celecoxib and flunixin on MSCs after grafting in vivo. The effects of NSAIDs were evaluated regarding cell viability and proliferation. Additionally, the multilineage differentiation capacity and cell migration was analysed. NSAIDs at lower concentrations (0.1-1 μM for celecoxib and meloxicam and 10-50 μM for flunixin) exert a positive effect on cell proliferation and migration, while at higher concentrations (10-200 μM for celecoxib and meloxicam and 100-1000 μM for flunixin and phenylbutazone), there is rather a negative influence. While there is hardly any influence on the adipogenic as well as on the chondrogenic MSC differentiation, the osteogenic differentiation potential, as demonstrated with the von Kossa staining, is significantly disturbed. Thus, it can be concluded that the effects of NSAIDs on MSCs are largely dependent on the concentrations used. Additionally, for some differentiation lineages, also the choice of NSAID is critical.
Publication Date: 2010-11-20 PubMed ID: 21087205DOI: 10.1042/CBI20090211Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research explored the impact of non-steroidal anti-inflammatory drugs (NSAIDs) on the growth, differentiation, and migration of equine mesenchymal stem cells (MSCs) in relation to stem cell therapy for orthopaedic diseases in horses.

Objective and Context

  • The research specifically looked at the effects of NSAIDs, particularly phenylbutazone, meloxicam, celecoxib and flunixin, on equine MSCs. These drugs are often applied in tandem with stem cell therapies in equine medicine, particularly in the treatment of orthopedic diseases.
  • The context for the study is the necessity to understand the influence of these NSAIDs on the viability and proliferation of MSCs, both in terms of in vitro and grafting in vivo applications.

Methods

  • The researchers examined the impact of different concentrations of NSAIDs on cell viability and proliferation.
  • Equipotential multidirectional differentiation and cell migration were also tested. Differentiation refers to the process by which an unspecialized cell becomes specialized into one of the many cell types that make up the body.
  • The study used different concentrations of NSAIDs, ranging from low (0.1-1 μM for celecoxib and meloxicam, and 10-50 μM for flunixin), to higher concentrations (10-200 μM for celecoxib and meloxicam, and 100-1000 μM for flunixin and phenylbutazone).

Findings

  • Lower concentrations of NSAIDs were found to have a positive influence on the proliferation and migration of MSCs, while higher concentrations resulted in negative effects.
  • Adipogenic and chondrogenic MSC differentiations were not notably affected by these NSAIDs, regardless of the concentrations used. Adipogenic relates to the formation of fat cells, while chondrogenic pertains to the formation of cartilage.
  • The osteogenic differentiation of MSCs (the process that leads to the formation of bone cells), however, was significantly disrupted, as demonstrated through von Kossa staining. This suggests that the application of NSAIDs, particularly at certain concentrations, could have potential implications for bone formation in stem cell therapy.

Conclusion

  • The research concluded that the effects of NSAIDs on MSCs are mainly dependent on the concentrations used.
  • Furthermore, the choice of NSAID is deemed critical for specific differentiation lineages, highlighting the need for careful selection and dosage of these drugs in the context of stem cell therapies in equine medicine.

Cite This Article

APA
Müller M, Raabe O, Addicks K, Wenisch S, Arnhold S. (2010). Effects of non-steroidal anti-inflammatory drugs on proliferation, differentiation and migration in equine mesenchymal stem cells. Cell Biol Int, 35(3), 235-248. https://doi.org/10.1042/CBI20090211

Publication

ISSN: 1095-8355
NlmUniqueID: 9307129
Country: England
Language: English
Volume: 35
Issue: 3
Pages: 235-248

Researcher Affiliations

Müller, Maike
  • Department of Anatomy I, University of Cologne, Cologne, Germany.
Raabe, Oksana
    Addicks, Klaus
      Wenisch, Sabine
        Arnhold, Stefan

          MeSH Terms

          • Aggrecans / genetics
          • Aggrecans / metabolism
          • Animals
          • Anti-Inflammatory Agents, Non-Steroidal / pharmacology
          • Bone Marrow Cells / cytology
          • Celecoxib
          • Cell Differentiation / drug effects
          • Cell Movement / drug effects
          • Cell Proliferation / drug effects
          • Clonixin / analogs & derivatives
          • Clonixin / pharmacology
          • Collagen Type II / genetics
          • Collagen Type II / metabolism
          • Core Binding Factor Alpha 1 Subunit / genetics
          • Core Binding Factor Alpha 1 Subunit / metabolism
          • Female
          • Horses
          • Male
          • Meloxicam
          • Mesenchymal Stem Cells / cytology
          • Mesenchymal Stem Cells / drug effects
          • Mesenchymal Stem Cells / metabolism
          • Phenylbutazone / pharmacology
          • Pyrazoles / pharmacology
          • Sulfonamides / pharmacology
          • Thiazines / pharmacology
          • Thiazoles / pharmacology

          Citations

          This article has been cited 30 times.